Predictive Immunological, Virological, and Routine Laboratory Markers for Critical COVID-19 on Admission

Table 1

Demographic characteristics and comorbidities of SARs-CoV-2-infected patients with mild, severe, and critical disease.

	Mild (n = 49)	Severe (n = 32)	Critical (n = 39)
Age, years, median (IQR)	51 (44.5–64.5)	61 (48.5–75.5)	66 (56–73)
Sex, women/men	32/17	16/16	7/32
Days from symptom onset on admission, median (IQR)	10 (4–16)	7 (5–13.7)	7 (5–10)
Chronic cardiovascular disease	9	4	8
Hypertension	13	7	17
COPD	6	3	5
Renal disease ()	1	2	1
Diabetes	5	3	10
Obesity (body mass index >30)	11	2	10
Pregnancy	2	0	1
Liver cirrhosis	1	1	2
Neurological disease (^†)	7	2	5
Active solid/hematological malignancy	4	0	1
HIV infection	3	0	1
Active smoker	12	3	7

Abbreviations: COPD, chronic obstructive pulmonary disease; HIV, human immunodeficiency virus; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2. () included advanced-stage renal disease, transplant recipient, or hemodialysis patients. (^†) included cerebral vascular disease and Parkinson disease.